d-Glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K

Biochemical and Biophysical Research Communications

Volumn 360, Issue 4, 2007, Pages 840-845

  Oh, Hyun Ji ^a   Lee, Jason S ^b   Song, Dae Kyu ^a   Shin, Dong Hoon ^a   Jang, Byeong Churl ^a   Suh, Seong Il ^a   Park, Jong Wook ^a   Suh, Min Ho ^a   Baek, Won Ki ^a  

^a Department of Internal Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Breast cancer; Cell proliferation; d Glucosamine; p70S6K; Prostate cancer; RPS6

Indexed keywords

GLUCOSAMINE; INITIATION FACTOR 4B; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; S6 KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

CELL PROLIFERATION; GLUCOSAMINE; HUMANS; NEOPLASMS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS;

EID: 34447576407     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.137     Document Type: Article

References (34)

1. Bruyere O., Pavelka K., Rovati L.C., Deroisy R., Olejarova M., Gatterova J., Giacovelli G., and Reginster J.Y. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 11 (2004) 138-143
2. Christgau S., Henrotin Y., Tanko L.B., Rovati L.C., Collette J., Bruyere O., Deroisy R., and Reginster J.Y. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin. Exp. Rheumatol. 22 (2004) 36-42
3. Quastel J.H., and Cantero A. Inhibition of tumour growth by d-glucosamine. Nature 171 (1953) 252-254
4. Bekesi J.G., Molnar Z., and Winzler R.J. Inhibitory effect of d-glucosamine and other sugar analogs on the viability and transplantability of ascites tumor cells. Cancer Res. 29 (1969) 353-359
5. Bekesi J.G., and Winzler R.J. Inhibitory effects of d-glucosamine on the growth of Walker 256 carcinosarcoma and on protein, RNA, and DNA synthesis. Cancer Res. 30 (1970) 2905-2912
6. Friedman S.J., and Skehan P. Membrane-active drugs potentiate the killing of tumor cells by d-glucosamine. Proc. Natl. Acad. Sci. USA 77 (1980) 1172-1176
7. Krug E., Zweibaum A., Schulz-Holstege C., and Keppler D. d-Glucosamine-induced changes in nucleotide metabolism and growth of colon-carcinoma cells in culture. Biochem. J. 217 (1984) 701-708
8. Bekesi J.G., Bekesi E., and Winzler R.J. Inhibitory effect of d-glucosamine and other sugars on the biosynthesis of protein, ribonucleic acid, and deoxyribonucleic acid in normal and neoplastic tissues. J. Biol. Chem. 244 (1969) 3766-3772
9. Bosmann H.B. Inhibition of protein, glycoprotein, ribonucleic acid and deoxyribonucleic acid synthesis by d-glucosamine and other sugars in mouse leukemic cells L5178Y and selective inhibition in SV-3T3 compared with 3T3 cells. Biochim. Biophys. Acta 240 (1971) 74-93
10. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 18 (2004) 1926-1945
11. Ruvinsky I., and Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31 (2006) 342-348
12. Radimerski T., Montagne J., Rintelen F., Stocker H., van der Kaay J., Downes C.P., Hafen E., and Thomas G. dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat. Cell Biol. 4 (2002) 251-255
13. Hornstein E., Tang H., and Meyuhas O. Mitogenic and nutritional signals are transduced into translational efficiency of TOP mRNAs. Cold Spring Harb. Symp. Quant. Biol. 66 (2001) 477-484
14. Gao N., Flynn D.C., Zhang Z., Zhong X.S., Walker V., Liu K.J., Shi X., and Jiang B.H. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am. J. Physiol. Cell Physiol. 287 (2004) C281-C291
15. Lee J.E., Kim K.M., Cho J.W., Suh S.I., Suh M.H., Kwon T.K., Park J.W., Bae J.H., Song D.K., Cho C.H., Bae I., and Baek W.K. Pyrrolidine dithiocarbamate induces cyclooxygenase-2 expression in NIH 3T3 fibroblast cells. Biochem. Biophys. Res. Commun. 298 (2002) 230-234
16. Wells L., Vosseller K., and Hart G.W. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell Mol. Life Sci. 60 (2003) 222-228
17. Slawson C., and Hart G.W. Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation. Curr. Opin. Struct. Biol. 13 (2003) 631-636
18. Andreozzi F., D'Alessandris C., Federici M., Laratta E., Del Guerra S., Del Prato S., Marchetti P., Lauro R., Perticone F., and Sesti G. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells. Endocrinology 145 (2004) 2845-2857
19. Vosseller K., Wells L., Lane M.D., and Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 99 (2002) 5313-5318
20. Singh L.P., Gennerette D., Simmons S., and Crook E.D. Glucose-induced insulin resistance of phosphatidylinositol 3'-OH kinase and AKT/PKB is mediated by the hexosamine biosynthesis pathway. J. Diabetes Complications 15 (2001) 88-96
21. Han J.W., Pearson R.B., Dennis P.B., and Thomas G. Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. J. Biol. Chem. 270 (1995) 21396-21403
22. Pearson R.B., Dennis P.B., Han J.W., Williamson N.A., Kozma S.C., Wettenhall R.E., and Thomas G. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14 (1995) 5279-5287
23. Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C., Hemmings B.A., and Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science 279 (1998) 707-710
24. Lane H.A., Fernandez A., Lamb N.J., and Thomas G. p70s6k function is essential for G1 progression. Nature 363 (1993) 170-172
25. Fingar D.C., Richardson C.J., Tee A.R., Cheatham L., Tsou C., and Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell Biol. 24 (2004) 200-216
26. Wang Z., Liang R., Huang G.S., Piao Y., Zhang Y.Q., Wang A.Q., Dong B.X., Feng J.L., Yang G.R., and Guo Y. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL. Apoptosis 11 (2006) 1851-1860
27. Masson E., Wiernsperger N., Lagarde M., and El Bawab S. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem. J. 388 (2005) 537-544
28. Mukhopadhyay N.K., Price D.J., Kyriakis J.M., Pelech S., Sanghera J., and Avruch J. An array of insulin-activated proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. J. Biol. Chem. 267 (1992) 3325-3335
29. Grammer T.C., Cheatham L., Chou M.M., and Blenis J. The p70S6K signalling pathway: a novel signalling system involved in growth regulation. Cancer Surv. 27 (1996) 271-292
30. Romanelli A., Martin K.A., Toker A., and Blenis J. p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol. Cell Biol. 19 (1999) 2921-2928
31. Burnett P.E., Barrow R.K., Cohen N.A., Snyder S.H., and Sabatini D.M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95 (1998) 1432-1437
32. Isotani S., Hara K., Tokunaga C., Inoue H., Avruch J., and Yonezawa K. Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J. Biol. Chem. 274 (1999) 34493-34498
33. Dennis P.B., Pullen N., Kozma S.C., and Thomas G. The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell Biol. 16 (1996) 6242-6251
34. Easton J.B., and Houghton P.J. mTOR and cancer therapy. Oncogene 25 (2006) 6436-6446